.png)
Raleigh, NC
Cindy Eckert, CEO and Founder of Sprout Pharmaceuticals, made history by bringing Addyi — the first and only FDA-approved drug for hypoactive sexual desire disorder (HSDD) in women, also known as low libido — to market. In 2015, Eckert sold Sprout Pharmaceuticals for a record-breaking $1 billion. She later fought to reacquire the company and reclaim control of Addyi to continue her mission of breaking down barriers in women’s sexual health and fighting for gender equity in healthcare. As a celebrated entrepreneur and fierce advocate for women’s sexual health with over 25 years of experience in sexual wellness and pharmaceuticals, Eckert’s impact extends beyond pharmaceuticals - she is known for her bold approach to business, commitment to fighting gender bias in medicine, and her fierce advocacy for
women’s health innovation. Eckert, who has made “the little pink pill” a personal lifestyle, has no plans to stop challenging inequities in healthcare, especially ahead of Addyi's 10-year anniversary this August.
Eckert’s work has earned recognition from The New York Times, which called Addyi, the “drug of a generation,” and Fortune has called her as a “tirelessforce of nature.” Along with being the cover of Entrepreneur Magazine, Eckert and Addyi have been celebrated by media like Goop, Inc, CNBC, Forbes, TIME, Fast Company, Financial Times, Vanity Fair, Bloomberg, CBS, Fox and many more.
Exhibit Hall Presentation: Wellness Rx the Next Trend is Sex -Sponsored By: ADDYI
Saturday, June 28, 2025
9:55 AM - 10:15 AM PDT